Dear All
We are intensifying our collaborative anti-malarial drug design efforts 
in 2015 with workshops planned starting in India and USA and continuing 
later in the year in Milan, Oxford, Toronto and Melbourne linking 
together the global community effort (www.scientistsagainstmalaria.net).

OpenTox tools will be deployed across the program in the holistic 
consensus-based screening of candidates for potential unwanted on- and 
off-target effects.

Please see upcoming program information if interesting in participating:

http://www.echeminfo.com/events/drug-discovery-india

and

http://www.echeminfo.com/events/drug-discovery-usa-2015

Please also contact me if interested in participating in OpenTox 
resource extension and use in neglected diseases research.

best regards
Barry

Barry Hardy PhD
Managing Director
Douglas Connect GmbH
Baermeggenweg 14
4314 Zeiningen
Switzerland

Tel: +41 61 851 0170

http://barryhardy.blogs.com/cheminfostream/